Search Results - N. L. Pogudina

Pharmacoeconomic analysis of using belimumab for the treatment of systemic lupus erythematosus by A. G. Tolkushin, N. L. Pogudina

Connect to this object online.

Individualized prophylactic treatment of patients with hemophilia A to improve effectiveness and optimize product consumption on the example of octocog alpha and rurioctocog alpha... by A. G. Tolkushin, M. E. Holownia-Voloskova, N. L. Pogudina

Connect to this object online.

COST-EFFECTIVENESS OF VILANEROL / UMECLIDINIUM VERSUS TIOTROPIUM IN SEVERE AND VERY SEVERE COPD by E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov

Connect to this object online.

Clinical and economic studies on pharmacotherapy of malignant neoplasms: the modeling approach by A. G. Tolkushin, S. K. Zyryanov, N. L. Pogudina, M. V. Davydovskaya

Connect to this object online.

Cost-effectiveness analysis of the use of mepolizumab in omalizumab-resistant patients with severe asthma by A. G. Tolkushin, V. A. Rogov, D. A. Ivanov, N. L. Pogudina

Connect to this object online.

COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD by E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov, N. L. Bondarenko, A. V. Karaulov

Connect to this object online.

COMPARATIVE COST-MINIMIZATION AND BUDGET-IMPACT ANALYSIS OF FIXED-DOSE INHALED CORTICOSTEROID / LONG-ACTING BETAAGONIST COMBINATIONS IN THE TREATMENT OF ASTHMA by N. L. Pogudina, E. G. Kosolapov, F. S. Kochenkov, A. V. Karaulov, N. L. Bondarenko, D. V. Blinov

Connect to this object online.